Supreme Court Quashed Criminal Complaint For NSQ Drug

  • News
  • April 21, 2017

The Supreme Court of India has taken stern view against the order of J&K High Court refusing to quash the Criminal Complaint filed by Drug Inspector, at Jammu against M/s Brawn Laboratories Ltd. As per judgment, Government Analyst, Patoli, Jammu vide its report dated 31.07.2009 declared the drug Not of Standard Quality. The company however vide letter 27.02.2010 conveyed to the Drug Inspector, that the method adopted for testing is not correct and also attached the report of testing which company got it from private lab. The company averted in its reply that “the result obtained after investigation of the finished product was found to be around97.35% and same was attached for your reference along with all the calculation sheet and chromatogram.”
Read More

  • Related Posts

    13 Years after Oxytocin Order, HC Seeks Compilance Status

    GWALIOR: The Gwalior Bench of the Madhya Pradesh High Court has directed the state government to submit a comprehensive compliance status report. This order addresses the implementation of the court’s…

    Centre Pushes Haryana to Fast-Track AIIMS Rewari

    New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gujarat FDCA cracks down on four firms for illegal drug sale; cancels licences of two

    Gujarat FDCA cracks down on four firms for illegal drug sale; cancels licences of two

    9,800 psychotropic tablets worth ₹2.53 crore seized in Mumbai’s Govandi

    9,800 psychotropic tablets worth ₹2.53 crore seized in Mumbai’s Govandi

    Story of Bariatric Surgery Joining One Family’s Battle Against Severe Obesity

    Story of Bariatric Surgery Joining One Family’s Battle Against Severe Obesity

    Maharashtra FDA Cancels Three Cadila Pharma Licences Over Aciloc, Aciloc+ Drug Mix-Up Risk

    Maharashtra FDA Cancels Three Cadila Pharma Licences Over Aciloc, Aciloc+ Drug Mix-Up Risk

    National Institute of Nutrition study finds strong link between diet quality and Rheumatoid Arthritis

    National Institute of Nutrition study finds strong link between diet quality and Rheumatoid Arthritis

    SIT raids three Bengaluru pharmacies, traces trail of fake medicine sales

    SIT raids three Bengaluru pharmacies, traces trail of fake medicine sales